Munson Healthcare is now offering Monoclonal Antibody (mAb) therapy to qualifying high-risk non-hospitalized outpatients diagnosed with COVID-19. This one-time infusion therapy will be available for treating providers to order for qualifying patients.
This therapy must be ordered by a referring provider. Patients will not be permitted to schedule themselves. Administration sites for this therapy will be located throughout the Munson Healthcare service area. Currently mAb infusion therapy is being offered in Cadillac, Grayling, Kalkaska, and Traverse City. We have many openings available.
For more information, read our complete FAQs for Providers. Referral Quick Guide, referral forms, and additional resources are available on our COVID-19 For Providers website.